Source: BioPortfolio

Dimension Therapeutics: Dimension Therapeutics Inc DMTX Financial and Strategic SWOT Analysis Review Report Updated 28092018 Prices from USD $300

SummaryDimension Therapeutics Inc Dimension Therapeutics is a developer of therapeutic products for the treatment of rare diseases associated with liver and genetic mutations. The company develops its product pipeline based on its mammalian adenoassociated...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Annalisa Jenkins's photo - CEO of Dimension Therapeutics

CEO

Annalisa Jenkins

CEO Approval Rating

79/100

Read more